33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial evaluating safety, efficacy, and PK of AMG 510, a novel KRASG12C inhibitor, in non-small cell lung cancer
    Meeting Abstract

    Govindan, R.; Fakih, M. G.; Price, T. J.; Falchook, G. S.; Desai, J.; Kuo, J. C.; Strickler, J. H.; Krauss, J. C.; Li, B. T.; Denlinger, C. S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • The TREAT model 2.0: Predicting lung cancer in patients seeking care in high-risk clinics
    Meeting Abstract

    Shipe, M.; Maiga, A.; Deppen, S.; Welty, V.; Blume, J.; Aldrich, M.; Montgomery, C.; Dickerson, A.; Crockett, J.; Vaszar, L.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Safety, efficacy, and pharmacokinetics of AMG 510, a novel KRAS(G12C) inhibitor, in patients with non-small cell lung cancer
    Meeting Abstract

    Govindan, R.; Fakih, M.; Price, T.; Falchook, G.; Desai, J.; Kuo, J.; Strickler, J.; Krauss, J.; Li, B.; Denlinger, C.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Meeting Abstract

    Brahmer, J.; Horn, L.; Hossein, B.; Ramalingam, S.; Pluzanski, A.; Burgio, M. A.; Garassino, M. C.; Chow, L. Q. M.; Gettinger, S.; Crino, L.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Using next-generation sequencing to identify genetic predictors of local failure after lung stereotactic body radiation therapy
    Meeting Abstract

    Ng, V.; Rimner, A.; Sidiqi, B.; Wu, A.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Lurbinectedin (L) combined with paclitaxel (P) or irinotecan (I) in relapsed SCLC. Results from two phase Lb trials
    Meeting Abstract

    Ponce, S.; Calvo, E.; De Miguel, M. J.; Sessa, C.; Flor, M. J.; Drilon, A.; Falcon, A.; Sanchez Simon, I.; Nuñez, R.; Luepke, X. E.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1 study of CA-170: First-in-class small molecule targeting VISTA/PD-L1 in patients with malignant pleural mesothelioma
    Meeting Abstract

    Zauderer, M.; Brody, J.; Marron, T.; Pacey, S.; Martell, R.; Wang, H.; Spicer, J.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • IASLC global survey for pathologists on PD-L1 testing for non-small cell lung cancer
    Meeting Abstract

    Mino-Kenudson, M.; Redman, M.; Hedger, J.; Daigneault, J.; Botling, J.; Brambilla, E.; Chen, G.; Chou, T.; Cooper, W.; Hirsch, F. R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Surgical outcomes of a multicenter phase II trial of neoadjuvant atezolizumab in resectable stages IB-IIIB NSCLC: Update on LCMC3 clinical trial
    Meeting Abstract

    Lee, J.; Chaft, J.; Nicholas, A.; Patterson, G.; Waqar, S.; Toloza, E.; Haura, E.; Raz, D.; Reckamp, K.; Merritt, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Transcriptional profiling of neoantigen specific T cells in resectable NSCLC treated with neoadjuvant anti-PD-1
    Meeting Abstract

    Caushi, J.; Ji, Z.; Zhang, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Guo, H.; Merghoub, T.; Wolchok, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save